the current standard of care for patients with essential thrombocythemia
Published 1 year ago • 5.8K plays • Length 3:21Download video MP4
Download video MP3
Similar videos
-
1:20
the current standard of care for patients with lower-risk mds
-
1:43
updates from a phase ii study of bomedemstat for the treatment of essential thrombocythemia
-
3:29
unmet needs and therapeutic strategies in essential thrombocythemia
-
8:07
essential thrombocythemia: outcomes, unmet needs, and therapeutic strategies
-
3:06
the unmet needs of essential thrombocythemia and polycythemia vera patients
-
2:24
update on phase iib study of bomedemstat in essential thrombocythemia
-
1:04
the current standard of care for mds-related cytopenias and how treatment strategies may evolve
-
1:57
surpass et: p1101 in essential thrombocythemia
-
29:13
essential thrombocythemia: pathogenesis and management
-
2:09:09
speciality updates in haematology
-
3:53
essential thrombocythemia watch & wait | what patients should know
-
1:23
developing a pro collection tool for patients with scd: key themes which are important to patients
-
0:58
the potential of car-t therapy targeting mutant calr in myelofibrosis & essential thrombocythemia
-
14:25
an overview of novel innovative treatments for patients with von willebrand disease
-
0:53
ukall60 : identifying the standard of care for elderly patients with all
-
1:47
bomedemstat normalizes platelet count for essential thrombocythemia
-
3:21
an insight into the standard of care in hr-mds and future outlooks
-
2:16
current and future treatment approaches for hr-mds
-
1:19
what's on the horizon for the treatment of mpns?
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
5:36
patient blood management – a new standard of care
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml